Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor

Journal of Endocrinology

Volumn 219, Issue 1, 2013, Pages 59-68

  Mabilleau, Guillaume ^a,b   Mieczkowska, Aleksandra ^a   Irwin, Nigel ^c   Flatt, Peter R ^c   Chappard, Daniel ^a,b  

^a UNIV Angers   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Bone matrix; Bone mineral; Bone quality; Bone strength; Glucagon like peptide 1

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MATRIX; BONE MINERAL; BONE RADIOGRAPHY; BONE STRENGTH; CONTROLLED STUDY; GENE DELETION; IMAGING; INFRARED SPECTROSCOPY; KNOCKOUT MOUSE; MALE; MICRO-COMPUTED TOMOGRAPHY; MICRORADIOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING; WILD TYPE;

BONE MATRIX; BONE MINERAL; BONE QUALITY; BONE STRENGTH; GLUCAGON-LIKE PEPTIDE-1;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; COLLAGEN; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, GLUCAGON; X-RAY MICROTOMOGRAPHY;

EID: 84884175131     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0146     Document Type: Article

References (42)

1. Ammann P, Badoud I, Barraud S, Dayer R & Rizzoli R 2007 Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. Journal of Bone and Mineral Research 22 1419-1425. (doi:10.1359/jbmr.070607)
2. Ayala JE, Bracy DP, James FD, Burmeister MA, Wasserman DH & Drucker DJ 2010 Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Endocrinology 151 4678-4687. (doi:10.1210/en.2010-0289)
3. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131-2157. (doi:10.1053/j.gastro.2007.03.054)
4. Bailey AJ, Sims TJ, Ebbesen EN, Mansell JP, Thomsen JS & Mosekilde L 1999 Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcified Tissue International 65 203-210. (doi:10.1007/s002239900683)
5. Bassett JH, van der Spek A, Gogakos A & Williams GR 2012 Quantitative X-ray imaging of rodent bone by Faxitron. Methods in Molecular Biology 816 499-506. (doi:10.1007/978-1-61779-415-5_29)
6. Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H et al. 2010 Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology 151 1473-1486. (doi:10.1210/en.2009-1272)
7. Boskey AL, DiCarlo E, Paschalis E, West P & Mendelsohn R 2005 Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporosis International 16 2031-2038. (doi:10.1007/ s00198-005-1992-3)
8. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ & Beamer WG 2005 Ovariectomy-induced bone loss varies among inbred strains of mice. Journal of Bone and Mineral Research 20 1085-1092. (doi:10.1359/ JBMR.050307)
9. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ & Muller R 2010 Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. Journal of Bone and Mineral Research 25 1468-1486. (doi:10.1002/jbmr.141)
10. Bullock BP, Heller RS & Habener JF 1996 Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 2968-2978. (doi:10.1210/en.137.7.2968)
11. Burr DB 2002 The contribution of the organic matrix to bone's material properties. Bone 31 8-11. (doi:10.1016/S8756-3282(02)00815-3)
12. Campos RV, Lee YC & Drucker DJ 1994 Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134 2156-2164. (doi:10.1210/ en.134.5.2156)
13. Chappard D, Basle MF, Legrand E & AudranM 2011 New laboratory tools in the assessment of bone quality. Osteoporosis International 22 2225-2240. (doi:10.1007/s00198-011-1573-6)
14. Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C & Thorens B 2009 Glucagon-like peptide-1 protects b-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes 58 1816-1825. (doi:10.2337/db09-0063)
15. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD & Karsenty G 2004 Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. Journal of Cell Biology 164 509-514. (doi:10.1083/ jcb.200312135)
16. Davey RA, Turner AG,McManus JF, ChiuWS, Tjahyono F, Moore AJ, AtkinsGJ,AndersonPH,MaC,GlattVet al. 2008 Calcitonin receptor plays a physiological role to protect against hypercalcemia inmice. Journal of Bone and Mineral Research 23 1182-1193. (doi:10.1359/jbmr.080310)
17. Drucker DJ & NauckMA 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 1696-1705. (doi:10.1016/S0140-6736(06)69705-5)
18. Elnenaei MO, Musto R, Alaghband-Zadeh J, Moniz C & Le Roux CW 2010 Postprandial bone turnover is independent of calories above 250 kcal. Annals of Clinical Biochemistry 47 318-320. (doi:10.1258/acb.2010. 010010)
19. Farlay D, Panczer G, Rey C, Delmas PD & Boivin G 2010 Mineral maturity and crystallinity index are distinct characteristics of bone mineral. Journal of Bone and Mineral Metabolism 28 433-445. (doi:10.1007/ s00774-009-0146-7)
20. Farlay D, Duclos ME, Gineyts E, Bertholon C, Viguet-Carrin S, Nallala J, Sockalingum GD, Bertrand D, Roger T, Hartmann DJ et al. 2011 The ratio 1660/1690 cm(K1) measured by infrared microspectroscopy is not specific of enzymatic collagen cross-links in bone tissue. PLoS ONE 6 e28736. (doi:10.1371/journal.pone.0028736)
21. Gaudin-Audrain C, Irwin N, Mansur S, Thorens B, Flatt PR, Basle MF, Chappard D & Mabilleau G 2013 Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone mass and quality in mice. Bone 53 221-230. (doi:10.1016/j.bone. 2012.11.039)
22. Hansotia T, Baggio LL, Delmeire D, Hinke SA, Yamada Y, Tsukiyama K, Seino Y, Holst JJ, Schuit F & Drucker DJ 2004 Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. Diabetes 53 1326-1335. (doi:10.2337/diabetes.53.5.1326)
23. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ & Christiansen C 2003 Role of gastrointestinal hormones in postprandial reduction of bone resorption. Journal of Bone and Mineral Research 18 2180-2189. (doi:10.1359/jbmr.2003.18.12.2180)
24. Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ et al. 2002 Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. Journal of Clinical Investigation 110 1849-1857. (doi:10.1172/JCI14218)
25. Judex S, Garman R, Squire M, Donahue LR & Rubin C 2004 Genetically based influences on the site-specific regulation of trabecular and cortical bone morphology. Journal of Bone and Mineral Research 19 600-606. (doi:10.1359/JBMR.040101)
26. Mabilleau G, Chappard D & Sabokbar A 2011 Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. Journal of Biological Chemistry 286 3242-3249. (doi:10.1074/jbc.M110.150300)
27. Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sjogren I, Andersen S, Andersen L, de Boer AS, Manova K, Barlas A et al. 2012 GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology 153 1538-1547. (doi:10.1210/en.2011-1864)
28. Merchenthaler I, Lane M & Shughrue P 1999 Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. Journal of Comparative Neurology 403 261-280. (doi:10.1002/(SICI)1096-9861(19990111)403:2!261:: AID-CNE8O3.0.CO;2-5)
29. Mieczkowska A, Basle MF, Chappard D & Mabilleau G 2012 Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism. Journal of Biological Chemistry 287 23517-23526. (doi:10.1074/jbc.M111.324814)
30. Moonga BS, Alam AS, Bevis PJ, Avaldi F, Soncini R, Huang CL & Zaidi M 1992 Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin. Journal of Endocrinology 132 241-249. (doi:10.1677/ joe.0.1320241)
31. Nuche-Berenguer B, Moreno P, Esbrit P, Dapia S, Caeiro JR, Cancelas J, Haro-Mora JJ & Villanueva-Penacarrillo ML 2009 Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulinresistant states. Calcified Tissue International 84 453-461. (doi:10.1007/ s00223-009-9220-3)
32. Nuche-Berenguer B, Moreno P, Portal-Nunez S, Dapia S, Esbrit P & Villanueva-Penacarrillo ML 2010 Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states. Regulatory Peptides 159 61-66. (doi:10.1016/j.regpep.2009.06.010)
33. Oliver WC & Pharr GM 1992 An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments. Journal of Materials Research 7 1564-1583. (doi:10.1557/JMR.1992.1564)
34. Paschalis EP, DiCarlo E, Betts F, Sherman P, Mendelsohn R & Boskey AL 1996 FTIR microspectroscopic analysis of human osteonal bone. Calcified Tissue International 59 480-487.
35. Paschalis EP, Verdelis K, Doty SB, Boskey AL,Mendelsohn R & Yamauchi M 2001 Spectroscopic characterization of collagen cross-links in bone. Journal of Bone and Mineral Research 16 1821-1828. (doi:10.1359/ jbmr.2001.16.10.1821)
36. Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE & Ager JW III 2008 Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone 43 798-812. (doi:10.1016/ j.bone.2008.04.027)
37. Roschger P, Fratzl P, Eschberger J & Klaushofer K 1998 Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23 319-326. (doi:10.1016/S8756-3282(98)00112-4)
38. Turner CH & Burr DB 1993 Basic biomechanical measurements of bone: a tutorial. Bone 14 595-608. (doi:10.1016/8756-3282(93)90081-K)
39. Wu T, Rayner CK, Jones K & Horowitz M 2010 Dietary effects on incretin hormone secretion. Vitamins and Hormones 84 81-110. (doi:10.1016/ S0083-6729(10)84015-4)
40. Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y & Inagaki N 2008 The murine glucagonlike peptide-1 receptor is essential for control of bone resorption. Endocrinology 149 574-579. (doi:10.1210/en.2007-1292)
41. ZaidiM, Datta HK, Moonga BS &MacIntyre I 1990 Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. Journal of Endocrinology 126 473-481. (doi:10.1677/joe.0.1260473)
42. Zioupos P, Currey JD & Hamer AJ 1999 The role of collagen in the declining mechanical properties of aging human cortical bone. Journal of Biomedical Materials Research 45 108-116. (doi:10.1002/(SICI)1097- 4636(199905)45:2!108::AID-JBM5O3.0.CO;2-A)